Common Contracts
9 similar Employment Agreement contracts by Innovive Pharmaceuticals, Inc., Cougar Biotechnology, Inc., Ivory Capital Corp, others
EMPLOYMENT AGREEMENTEmployment Agreement • December 8th, 2006 • Novadel Pharma Inc • Pharmaceutical preparations • New Jersey
AGREEMENT (the “Agreement”), dated as of December 4, 2006 by and between NOVADEL PHARMA INC., a Delaware corporation with principal executive offices at 25 Minneakoning Rd., Flemington, New Jersey 08822 (the “Company”), and DAVID H. BERGSTROM, Ph.D. residing at 15 Kerby Lane, Mendham, New Jersey 07945-2901 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 2nd, 2006 • Cougar Biotechnology, Inc. • Pharmaceutical preparations • New York
This AGREEMENT (the “Agreement”) is made this 28th day of September, 2006, by and between COUGAR BIOTECHNOLOGY, INC., a Delaware corporation with principal executive offices at 10990 Wilshire Boulevard, Suite 1200, Los Angeles, CA 90024 (the “Company”), and ALAN H. AUERBACH (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 3rd, 2006 • Cougar Biotechnology, Inc. • Blank checks • New York
This AGREEMENT (the “Agreement”) is made this 16th day of May 2003, by and between COUGAR BIOTECHNOLOGY, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and ALAN AUERBACH, residing at 447 Herondo Street, #208, Hermosa Beach, California 90254 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 9th, 2006 • Innovive Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
This Agreement (this “Agreement”), dated as of June 2, 2004 (sometimes the “Effective Date”), by and between BROADWAY THERAPEUTICS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and STEVEN KELLY., residing at 83 Mercer Street, Apt. #3, New York, NY 10012 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • New York
This Agreement (this “Agreement”), dated as of March 4, 2005 (sometimes the “Effective Date”), by and between INNOVIVE PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and ERIC POMA, residing at 165 Christopher Street, #4I, New York New York 10014 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • New York
This Agreement (this “Agreement”), dated as of April 7, 2005 (sometimes the “Effective Date”), by and between INNOVIVE PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and Adam R. Craig, residing at 10 Allen Circle, Boxford, MA 01921 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2005 • Innovive Pharmaceuticals, Inc. • New York
This Agreement (this “Agreement”), dated as of June 2, 2004 (sometimes the “Effective Date”), by and between BROADWAY THERAPEUTICS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and STEVEN KELLY., residing at 83 Mercer Street, Apt. #3, New York, NY 10012 (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 15th, 2005 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
This AGREEMENT (the “Agreement”), dated as of January 3, 2005, by and between MANHATTAN PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 810 Seventh Avenue, 4th Floor, New York, NY 10019 (the “Company”), and Nicholas J. Rossettos, residing at 449 West 56th Street, Apt. 7D, New York, New York (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 16th, 2005 • Ivory Capital Corp • Blank checks • New York
AGREEMENT (the “Agreement”), dated as of April 2, 2004, by and between Aspen Therapeutics, Inc., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and DR. SIMON PEDDER, residing at 11432 James Jack Lane, Charlotte, NC, 28277 (the “Executive”).
